Genovis AB (publ.) Cash Flow Reinvestment Rate

Latest as of December 2025: 1.00x

Genovis AB (publ.) cash flow reinvestment rate. Genovis AB (publ.) (GENO) has a Cash Flow Reinvestment Rate of 1.00x as of December 2025, reinvesting Skr15.90 Million (capex Skr15.90 Million ) from operating cash flow of Skr15.90 Million. Explore GENO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.00x
(Capex + Investments) / Operating CF

Total Reinvested

Skr15.90 Million
Capex + Investments

Operating Cash Flow

Skr15.90 Million
SEK

Capital Expenditures

Skr15.90 Million
SEK

Cash Flow Reinvestment Rate of Genovis AB (publ.) (2019–2025)

Cash flow reinvestment rate of Genovis AB (publ.) from 2019 to 2025. Historical reinvestment intensity for Genovis AB (publ.) across 6 annual periods. Explore Genovis AB (publ.) capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Genovis AB (publ.) Cash Flow Reinvestment Rate by Year (2019–2025)

Genovis AB (publ.) cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Genovis AB (publ.). For the full cash flow conversion analysis, see GENO cash flow conversion.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2025 1.00x Skr32.02 Million Skr32.02 Million Skr32.02 Million ▲ +139.3%
2024 0.42x Skr15.51 Million Skr37.12 Million Skr1.09 Million ▼ -47.5%
2023 0.80x Skr53.94 Million Skr67.75 Million Skr12.81 Million ▲ +493.8%
2021 0.13x Skr6.16 Million Skr45.92 Million Skr4.49 Million ▼ -97.7%
2020 5.88x Skr22.10 Million Skr3.76 Million Skr20.43 Million ▲ +1032.5%
2019 0.52x Skr6.82 Million Skr13.13 Million Skr5.15 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow